Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Health In TechHIT -3.40%19 Net Cash per Share is $-0.08 as of Jun. 2026. GuruFocus rates HIT with a GF Score™ of 19/100. The stock has 3 warning signs investors should review. Among 860 Software companies, Health In Tech ranks worse than 116278.95% on this metric.
The historical rank and industry rank for Health In Tech's Net Cash per Share or its related term are showing as below:
During the past 4 years, the highest Price-to-Net-Cash Ratio of Health In Tech was 80.25. The lowest was 22.00. And the median was 53.28.
HIT's Price-to-Net-Cash is not ranked *
in the Software industry.
Industry Median: 8.13 * Ranked among companies with meaningful Price-to-Net-Cash only.
Health In Tech (NAS:HIT) Net Cash per Share Explanation
Ben Graham invested in situations where the company's stock price was lower than its net-cash. He assigned some value to the company's other current asset. The value is called Net Current Asset Value (NCAV). One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.
You can find companies that are traded below their Net Current Asset Value (NCAV) with our Net-Net screener.
Health In Tech Net Cash per Share Related Terms
Health In Tech Net Cash per Share Historical Data
* Premium members only.
The historical data trend for Health In Tech's Net Cash per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HIT vs IDN, RSSS, SCOR: Net Cash per Share Comparison
For the Software - Application subindustry, Health In Tech's Price-to-Net-Cash, along with its competitors' market caps and Price-to-Net-Cash data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Health In Tech Price-to-Net-Cash vs Software Industry
For the Software industry and Technology sector, Health In Tech's Price-to-Net-Cash distribution charts can be found below:
* The bar in red indicates where Health In Tech's Price-to-Net-Cash falls into.
In the calculation of a company's Net Cash per Share, assets other than cash and short term investments are considered to be worth nothing. But the company has to pay its debt and other liabilities in full. This is an extremely conservative way of valuation. Most companies have negative Net Cash per Share. But sometimes a company's price may be lower than its net-cash.
Health In Tech's Net Cash per Share for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Health In Tech (HIT) has a Net Cash per Share of $-0.08 as of Jun. 2026. Net cash per share equals the per-share value of cash and equivalents less total liabilities and minority interest. View historical data on Health In Tech and its competitors. According to the industry distribution chart, Health In Tech ranks #999999 out of 860 companies in the Software industry.
Is Health In Tech's Net Cash per Share too high?
Health In Tech's current Net Cash per Share is $-0.08. Based on the distribution chart, Health In Tech ranks #999999 out of 860 companies in the Software industry, which is in the bottom quartile relative to peers. Overall, Health In Tech has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Health In Tech's Net Cash per Share compare to IDN and RSSS?
According to the Software industry distribution chart, Health In Tech ranks #999999 out of 860 companies for Net Cash per Share. This places Health In Tech in the lower half of its industry. The industry median Net Cash per Share is 8.13. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Cash per Share for a Software company?
The median Net Cash per Share among Software companies is 8.13, based on 860 companies in the industry. Companies in the top quartile (top 25%) have a Net Cash per Share significantly above this median, while those in the bottom quartile fall well below. However, Net Cash per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Cash per Share mean?
A high Net Cash per Share can signal that a stock is expensive relative to its fundamentals. Net cash per share equals the per-share value of cash and equivalents less total liabilities and minority interest. View historical data on Health In Tech and its competitors. For the Software industry, the median Net Cash per Share is 8.13 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Health In Tech's current Net Cash per Share is $-0.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Health In Tech stock overvalued right now?
Health In Tech (HIT) has a current Net Cash per Share of $-0.08. The current Net Cash per Share is $-0.08. Health In Tech's overall GF Score™ is 19/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Cash per Share calculated?
Net Cash per Share is calculated from a company's financial statements. For Health In Tech (HIT), the current Net Cash per Share is $-0.08 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Health In Tech Inc is an AI-enabled insurance technology platform company that offers a marketplace that improves processes in the healthcare industry through vertical integration, process simplification, and automation. By removing friction and complexities, it streamlines the underwriting, sales, and service process for insurance companies, licensed brokers, Managing General Underwriter (MGUs), and third-party administrators (TPAs). The company's platform serves as a marketplace for brokers, TPAs, MGUs and carriers with self-funded health insurance options for employers. The platform includes functions such as plan customization, stop-loss quoting, underwriting, claims administration, and reporting integration.
19GF Score
Get the complete analysis for HIT
Net Cash per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HIT has been successfully added to your 
